USPTO 2015–2025 USPTO PatentsView US Corporation

Biomet Sports Medicine, LLC

USPTO PatentsView assignee record — 196 granted patents across 7 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

196
Total patents granted
7
CPC technology areas
19.9
Avg claims per patent
-34%
5-year filing velocity

Portfolio overview

Biomet Sports Medicine, LLC has been granted 196 US utility patents between 2015 and 2025, placing Biomet Sports Medicine, LLC at rank #2,029 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.9 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Biomet Sports Medicine, LLC is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 42.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 78 grants, compared with 118 in the 2015–2019 window — a -34% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Biomet Sports Medicine, LLC's 19.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 7 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Biomet Sports Medicine, LLC against peers pursuing similar technology classes.

How does Biomet compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Biomet holds 196 patents — placing it at rank #2,029 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

010203040 20152016201720182019202020212022202320242025 10
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Biomet Sports Medicine, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 21 10.7%
2016 31 15.8%
2017 27 13.8%
2018 21 10.7%
2019 18 9.2%
2020 24 12.2%
2021 15 7.7%
2022 13 6.6%
2023 10 5.1%
2024 6 3.1%
2025 10 5.1%

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Focused
Claim Depth Standard
Velocity Declining

Where it ranks

Overall rank by patents

#2,029

Across all tracked assignees

Innovation Score

42.9 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Biomet Sports Medicine, LLC hold?
Biomet Sports Medicine, LLC holds 196 US granted patents filed between 2015 and 2025, spanning 7 technology areas.
What is Biomet Sports Medicine, LLC's Innovation Score?
Biomet Sports Medicine, LLC has an Innovation Score of 42.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Biomet Sports Medicine, LLC focus on?
Biomet Sports Medicine, LLC's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 194 patents. The company has filed patents in 7 CPC subclasses total.
Is Biomet Sports Medicine, LLC's patent filing rate increasing or decreasing?
Biomet Sports Medicine, LLC's recent filing velocity is -34% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Biomet Sports Medicine, LLC's patents?
Biomet Sports Medicine, LLC's patents average 19.9 claims each. This falls within the standard range, providing solid legal coverage.
How is the Biomet Sports Medicine, LLC patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope